Select Language

HLA-A*0201 & B2M & Survivin (TLPPAWQPFL)

HLA-A*0201 & B2M & Survivin (TLPPAWQPFL) Product List

Product Category
Protein (2)
Product Status
Launched (2)
Species
Human (2)
Tag
His Tag & Avi Tag (1)His Tag (1)
Conjugate
Biotin-labeled (1)PE Labeled (1)

Cat. No.	Species	Host	Product Description	Structure	Purity	Feature
HLN-H82E5	Human	HEK293	Biotinylated Human HLA-A*02:01&B2M&Survivin (TLPPAWQPFL) Complex Protein (Monomer, MALS verified)
HLN-HP2H9	Human	HEK293	PE-Labeled Human HLA-A*02:01&B2M&Survivin (TLPPAWQPFL) Tetramer Protein

Total: 2

HLA-A*0201 & B2M & Survivin (TLPPAWQPFL) Background

Survivin, also known as BIRC5 and EPR-1, is a member of the inhibitor of apoptosis (IAP) family, which encodes negative regulatory proteins that prevent apoptotic cell death. IAP family members usually contain multiple baculovirus IAP repeat (BIR) domains, but birc5 encodes proteins with only a single BIR domain. The Human HLA-A*0201 Survivin (TLPPAWQPFL) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M and TLPPAWQPFL peptide of the Survivin.

Clinical Drug Information

English Name	Research Code	Highest Development Stage	Company	Indication	Clinical Trial
AFX-5931	AFX-5931	Phase 2 Clinical		Eczema	Details
MW-151	MW01-9-034WH; MW-151; MW01-2-151SRM	Phase 1 Clinical	University Of Kentucky	Drug-Related Side Effects and Adverse Reactions; Poisoning; Cognition Disorders	Details
64CU-DOTA-ECL1i		Phase 1 Clinical	Washington University School Of Medicine	Carotid Artery Diseases; Heart Diseases; Arteriosclerosis	Details